Esoz L Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to manage gastrointestinal disorders effectively. Levosulpiride, a selective dopamine D2 receptor antagonist, enhances gastrointestinal motility and exhibits prokinetic properties, making it beneficial in treating conditions like dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the stomach lining, thereby providing symptomatic relief from acid-related disorders such as GERD, erosive esophagitis, and peptic ulcers. The sustained-release formulation ensures a prolonged therapeutic effect, improving patient compliance and symptom control. Esoz L Capsule SR is typically prescribed for patients experiencing upper gastrointestinal symptoms including heartburn, acid regurgitation, nausea, and bloating associated with functional dyspepsia and acid peptic diseases. It is important to use this medication under medical supervision, as improper use may lead to side effects such as headache, dizziness, or gastrointestinal disturbances. Patients with known hypersensitivity to either component or those with severe liver or kidney impairment should avoid this medication. Overall, Esoz L Capsule SR offers a dual-action approach by combining acid suppression with enhanced gastric motility, providing comprehensive relief from complex gastrointestinal conditions.